Get the fundamentals right
Fundamental analysis is simply the ability to understand why the market is moving in a certain direction. Some simple ways to fast track your fundamental analysis skills are to invest in a news squawk, read analysts regularly, and get some 1:1 coaching. It will be an investment that will pay dividends in

Via Reuters

September 15
Other markets
– FTSE +1.04%
– Euro Stoxx +0.55%
– Dax+ 0.34 %
– Bitcoin +1.82%
– Gold +0.66%
– US oil +1.58 %
GBP and NZD firm against the USD

Via BBC’s Kuensberg
Here are her tweets. October deadline for furlough scheme looks set for now. Bearish pressures mounting for the GBP inn the bigger picture. 

It’s all in your head
It is easy to see why trading psychology is an area that is often overlooked by traders, especially when they are starting out. However, seasoned traders, who have spent years in the markets, understand that the traders who are going to keep going for the long haul are those who have

Positive risk sentiment on vaccine hopes
The session started with a positive hand over from Asia that translated into a positive  European cash open and strength inUS equity futures. Positive vaccine sentiment from AstraZeneca and Pfizer helped to keep sentiment buoyed though yields were less positive than the early equity moves. The sentiment moderated as the

OPEC
Oil rising higher. Now at 37.27. Probably not as bad as the market was fearing. High compliance is good, especially with compliance normally an issue. 

Early optimism fades a little
The early vaccine optimism is fading a little as European equity markets drift towards flat for the day. US futures markets have also taken a dip lower in the last 30 mins of trading joining the lower bond yields and weakness in oil ahead of the OPEC oil market report at

Via Bloomberg
Great point on the Bloomberg’s Market’s live blog. 
The ECB’s verbal interventions against euro strength is a pain for the SNB. The SNB want the euro higher against the CHF to help their export economy. The ECB want the euro lower to support theirs. 

You’ll recall last week that clinical trials of the  COVID-19 vaccine candidate from Oxford / AstraZeneca were paused:
News now that AstraZeneca said it received notification from the UK’s Medicines Health Regulatory Authority that it was safe to resume clinical trials.